Filing Details
- Accession Number:
- 0001179110-14-016211
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-05 20:06:44
- Reporting Period:
- 2014-11-03
- Filing Date:
- 2014-11-05
- Accepted Time:
- 2014-11-05 20:06:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1334682 | H Gregg Alton | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Evp, Corp & Med Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-11-03 | 31,000 | $23.76 | 151,694 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-11-03 | 19,658 | $109.89 | 132,036 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-11-03 | 3,350 | $110.45 | 128,686 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-11-03 | 6,877 | $111.89 | 121,809 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-11-03 | 1,115 | $112.45 | 120,694 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-11-03 | 1,100 | $109.86 | 119,594 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-11-03 | 300 | $110.44 | 119,294 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-11-03 | 600 | $112.04 | 118,694 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-11-03 | 31,000 | $0.00 | 31,000 | $23.76 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
42,367 | 2020-01-28 | No | 4 | M | Direct |
Footnotes
- The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
- Sale prices reported for the transactions reported here range from $109.2976 to $110.2971. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $110.2976 to $111.25. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $111.34 to $112.32. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $112.40 to $112.55. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $109.29 to $110.27. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $110.31 to $110.58. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $111.66 to $112.47. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.